• Profile
Close

Utility of 18 F-AlF-NOTA-octreotide PET/CT in the localization of tumor-induced osteomalacia

Journal of Clinical Endocrinology and Metabolism Apr 22, 2021

Long T, Hou J, Yang N, et al. - In this retrospective analysis, researchers sought to assess the effectiveness of 18 F-AlF-NOTA-octreotide ( 18 F-OC) PET/CT in detecting tumor-induced osteomalacia (TIO) and its impact on patient management. The sample consisted of 17 patients with hypophosphatemic osteomalacia suspected of TIO. 18 F-OC PET/CT study was conducted in all 17 patients to localize the tumor. The 18 F-OC PET/CT scan can help detect tumors that cause TIO. To confirm the findings, further research with a larger patient population is needed.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay